LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

LLY

769.87

+0.76%↑

JNJ

155.03

+1.03%↑

ABBV

189.89

+1.42%↑

NVO

74.74

+3.06%↑

UNH

303.11

+2.59%↑

Search

Hologic Inc

Chiusa

SettoreSettore sanitario

64.32 2.11

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

62.96

Massimo

64.57

Metriche Chiave

By Trading Economics

Entrata

-218M

-17M

Vendite

-17M

1B

P/E

Media del settore

26.055

51.198

EPS

1.03

Margine di Profitto

-1.731

Dipendenti

7,063

EBITDA

-359M

-7M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+5.36% upside

Dividendi

By Dow Jones

Utili prossimi

28 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-1.1B

14B

Apertura precedente

62.21

Chiusura precedente

64.32

Notizie sul Sentiment di mercato

By Acuity

24%

76%

56 / 380 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Bullish Evidence

Hologic Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

27 mag 2025, 18:46 UTC

I principali Market Mover
Acquisizioni, Fusioni, Takeovers

Hologic Shares Up Following Report of Buyout Offer From TPG, Blackstone

27 mag 2025, 20:07 UTC

Acquisizioni, Fusioni, Takeovers

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 mag 2025, 19:06 UTC

Acquisizioni, Fusioni, Takeovers

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 14%. -- Barrons.com

27 mag 2025, 18:26 UTC

Acquisizioni, Fusioni, Takeovers

Hologic Stock Is Surging. Why Shares of the MedTech Company Are Up 19%. -- Barrons.com

Confronto tra pari

Modifica del prezzo

Hologic Inc Previsione

Obiettivo di Prezzo

By TipRanks

5.36% in crescita

Previsioni per 12 mesi

Media 66.45 USD  5.36%

Alto 71 USD

Basso 60 USD

Basato su 14 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Hologic Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

14 ratings

5

Acquista

9

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

52.69 / 58.605Supporto e resistenza

A breve termine

Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bearish Evidence

Sentiment

By Acuity

56 / 380 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Prove rialziste molto forti

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sopra la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Hologic Inc

Hologic, Inc. engages in the development, manufacture, and supply of diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment worldwide. The company operates through four segments: Diagnostics, Breast Health, GYN Surgical, and Skeletal Health. It provides Aptima molecular diagnostic assays to detect the infectious microorganisms; Aptima viral load assays for Hepatitis B virus, Hepatitis C virus, human immunodeficiency virus, and human cytomegalo virus; Aptima bacterial vaginosis and candida vaginitis assays for the diagnosis of vaginitis; Aptima SARS-CoV-2 and Panther Fusion SARS-CoV-2 assays to detect SARS-CoV-2; ThinPrep System for cytology applications; and Rapid Fetal Fibronectin Test that assists physicians in assessing the risk of pre-term birth. The company also offers breast cancer care solutions in the areas of radiology, breast surgery, pathology, and treatment, such as 3D digital mammography systems, image analytics software, reading workstations, minimally invasive breast biopsy guidance systems, breast biopsy site markers, localization, and specimen radiology solutions; and breast conserving surgery products. In addition, it provides MyoSure Hysteroscopic Tissue Removal System for the removal of fibroids and polyps in the uterus; NovaSure Endometrial Ablation System to treat abnormal uterine bleeding; Fluent Fluid Management System that provides liquid distention during diagnostic and operative hysteroscopic procedures; Acessa ProVu system to treat various fibroids; and CoolSeal portfolio, such as bipolar vessel sealing devices. Further, it offers Horizon DXA, a dual energy X-ray system; and Fluoroscan Insight FD mini C-arm to perform minimally invasive orthopedic surgical procedures. It sells its products through direct sales, service forces, independent distributors, and sales representatives. The company was incorporated in 1985 and is headquartered in Marlborough, Massachusetts.